Characteristic | Total (n= 41) | Intervention (n= 21) | Usual care (n= 20) |
---|---|---|---|
Mean age, years (SD) | 64.2 (10.8) | 63.2 (10.0) | 65.3 (11.7) |
Male sex, n (%) | 23 (56.1) | 13 (61.9) | 10 (50.0) |
Mean BMI, mg/kg2 (SD)a | 28.4 (4.5) | 28.7 (4.5) | 28.0 (4.7) |
Obesity, BMI ≥30 mg/kg2, n (%) | 9 (22.0) | 5 (23.8) | 4 (20.0) |
Hypertension, n (%) | 28 (68.3) | 13 (61.9) | 15 (75.0) |
Smoking status, n (%) | |||
Never | 12 (29.3) | 4 (19.0) | 8 (40.0) |
Current or prior | 11 (26.8) | 6 (28.6) | 5 (25.0) |
Unknown | 18 (43.9) | 11 (52.4) | 7 (35.0) |
Diabetes, n (%) | 11 (26.8) | 6 (28.6) | 5 (25.0) |
Hypercholesterolaemia, n (%) | 23 (56.1) | 13 (61.9) | 10 (50.0) |
Coronary artery disease, n (%)b | 6 (14.6) | 2 (9.5) | 4 (20.0) |
Chronic kidney disease (eGFR <60 ml/min), n (%) | 8 (19.5) | 5 (23.8) | 3 (15.0) |
Ischaemic or haemorrhagic stroke, n (%) | 5 (12.2) | 4 (19.0) | 1 (5.0) |
Chronic obstructive pulmonary disease, n (%)c | 14 (34.1) | 6 (28.6) | 8 (40.0) |
Immunocompromised, n (%) | 3 (7.3) | 1 (4.8) | 2 (10.0) |
Charlson Comorbidity Index, modified, 8/17 items (SD)d | 1.20 (1.14) | 1.24 (1.22) | 1.15 (1.09) |
COVID-19 confirmed with PCR SARS-CoV-2-test, n (%) | 40 (97.6) | 21 (100) | 19 (95.0) |
Median number of days with symptoms before inclusion (range) | 7.0 (0–20) | 7.0 (0–15) | 6.5 (2–20) |
↵a Missing n= 12.
↵b Including angina pectoris, myocardial infarction, and heart failure.
↵c Including asthma and chronic obstructive pulmonary disease.
↵d Data of 8/17 items of the International Classification of Diseases, 10th Revision version of the Charlson Comorbidity Index was used. Total score range 0–10. BMI = body mass index. eGFR = estimated glomerular filtration rate. PCR = polymerase chain reaction. SD = standard deviation.